UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062960
Receipt number R000072090
Scientific Title Effects of Different Wheelchair Seat Surfaces on Interface Pressure Distribution and Perceived Comfort: An Exploratory Randomized Crossover Trial
Date of disclosure of the study information 2026/09/17
Last modified on 2026/09/17 14:50:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Different Wheelchair Seat Surfaces on Interface Pressure Distribution and Perceived Comfort

Acronym

Effects of Different Wheelchair Seat Surfaces

Scientific Title

Effects of Different Wheelchair Seat Surfaces on Interface Pressure Distribution and Perceived Comfort: An Exploratory Randomized Crossover Trial

Scientific Title:Acronym

Effects of Different Wheelchair Seat Surfaces

Region

Japan


Condition

Condition

Wheelchair users and healthy individuals

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of different wheelchair seat surfaces.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Peak interface pressure

Key secondary outcomes

Contact area
asymmetry
High-pressure area
Seating comfort
Perceived stability
Discomfort


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Wheelchair seat made of elastic woven fabric

Interventions/Control_2

Conventional wheelchair seat made of nylon fabric

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Inclusion Criteria for the Wheelchair User Group
Individuals who use a wheelchair on a daily basis.
Individuals classified as Level1 on the Hoffer Sitting Ability Classification.
Individuals who understand the study information and can provide informed consent.
Individuals who can understand the assessor's instructions and complete self-reported assessments.
Individuals considered able to undergo the measurements safely at an adult day-care facility or similar setting.

Inclusion Criteria for the Healthy Adult Group
Healthy adults who understand the study information and can provide informed consent.

Key exclusion criteria

Exclusion Criteria for the Wheelchair User Group
Individuals who have difficulty understanding the study information or measurement instructions because of severe cognitive impairment, aphasia, higher cortical dysfunction, or a similar condition.
Individuals who are unable to maintain a quiet seated position during measurements or who have marked involuntary movements.
Individuals with active pressure injuries, wounds, or severe skin lesions on the buttocks or posterior thighs.
Individuals who are unable to continue the measurements because of severe pain or distress.
Individuals who are unable to maintain the standardized sitting posture because of severe spinal deformity, pelvic deformity, joint contracture, or a similar condition.
Individuals whose body weight exceeds the safe operating limit of the measurement equipment or study wheelchair.
Individuals considered unsuitable for participation by the principal investigator or the therapist responsible for the assessment.

Exclusion Criteria for the Healthy Adult Group
Individuals with a medical history or condition that makes it difficult to maintain a seated position, those with pain or skin lesions on the buttocks or thighs, or those considered unable to undergo the measurements safely.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Ryu
Middle name
Last name Kokuwa

Organization

Syupoon Inc.

Division name

Department of Paracane and Lococane

Zip code

4980026

Address

43, Nishimaeshinden, Uguiura, Yatomi, Aichi, 498-0026, JAPAN

TEL

0567558253

Email

kokuwa@welloop.co.jp


Public contact

Name of contact person

1st name Ryu
Middle name
Last name Kokuwa

Organization

Syupoon Inc.

Division name

Department of Paracane and Lococane

Zip code

4980026

Address

43, Nishimaeshinden, Uguiura, Yatomi, Aichi, 498-0026, JAPAN

TEL

0567558253

Homepage URL


Email

kokuwa@welloop.co.jp


Sponsor or person

Institute

Welloop Inc.

Institute

Department

Personal name

Ryu Kokuwa


Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)

Toray Industries, Inc.


IRB Contact (For public release)

Organization

Welloop Inc. Research Ethics Review Committee

Address

43, Nishimaeshinden, Uguiura, Yatomi, Aichi, 498-0026, JAPAN

Tel

0567558253

Email

tomoko@welloop.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 09 Month 01 Day

Date of IRB

2026 Year 09 Month 07 Day

Anticipated trial start date

2026 Year 09 Month 07 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 09 Month 17 Day

Last modified on

2026 Year 09 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072090